Adenovirus type-35 vectors block human CD4+ T-cell activation via CD46 ligation.
about
The CD46-Jagged1 interaction is critical for human TH1 immunityAdenovirus serotype 5 vectors with Tat-PTD modified hexon and serotype 35 fiber show greatly enhanced transduction capacity of primary cell cultures.Long-term humoral and cellular immune responses elicited by a heterologous Plasmodium vivax apical membrane antigen 1 protein prime/adenovirus boost immunization protocol.Type I IFN induced by adenovirus serotypes 28 and 35 has multiple effects on T cell immunogenicityThe number of Toll-like receptor 9-agonist motifs in the adenovirus genome correlates with induction of dendritic cell maturation by adenovirus immune complexesViral Manipulation of Host Inhibitory Receptor Signaling for Immune Evasion.Vaccination with adenovirus serotypes 35, 26, and 48 elicits higher levels of innate cytokine responses than adenovirus serotype 5 in rhesus monkeysClinical features of community acquired adenovirus pneumonia during the 2011 community outbreak in Southern Taiwan: role of host immune response.Transient removal of CD46 is safe and increases B-cell depletion by rituximab in CD46 transgenic mice and macaques.The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domains.Adenovirus serotype 26 and 35 vectors induce simian immunodeficiency virus-specific T lymphocyte responses in foreskin in rhesus monkeys.Synergism/complementarity of recombinant adenoviral vectors and other vaccination platforms during induction of protective immunity against malaria.Enhanced antitumor immunotherapeutic effect of B-cell-based vaccine transduced with modified adenoviral vector containing type 35 fiber structures.Recombinant Ad35 adenoviral proteins as potent modulators of human T cell activation.Chimpanzee adenoviral vectors as vaccines - challenges to move the technology into the fast lane.Designer Oncolytic Adenovirus: Coming of Age.
P2860
Q24301407-BF131070-52CA-430C-91F9-43934B79AC71Q34571474-97DDC846-D694-43CC-A7F8-C5D360AAD56FQ35191980-A4F91692-2612-4FF7-A7A2-425ECC26597AQ36016455-95C84B3E-1B8A-4353-81AC-D42655784486Q36023055-3CDA4002-B5D5-48A5-9A9A-685023C45F1DQ36120111-4A216C67-B549-4877-8EB8-E6FDCD1B046CQ36246264-F8D8E1F8-12F8-4BFE-BA92-027AC3353915Q36299977-E68C8D98-B9A4-473D-B40A-FCDB3B612D8BQ36673736-ED06F5CF-7DDE-47AD-8CAF-9098C0921255Q36978855-8E592086-BB9F-4323-973B-90FD53CE0E81Q37713545-D4F65525-AC33-444B-82AA-ED48DD0A155EQ37924616-AEA2C1FA-6893-4E1E-937E-C16DB1F6FBF4Q42255825-F579CF29-CFB6-43A0-8374-462269D6266AQ46750116-C2E221B7-8743-4F5E-8C26-EE3197B9CD1DQ47607706-754C640F-13CF-4F2A-A1F9-CE1B5C66B6CAQ55467684-96AC732E-4AF7-4FFC-ACF6-0EF725FB973E
P2860
Adenovirus type-35 vectors block human CD4+ T-cell activation via CD46 ligation.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Adenovirus type-35 vectors block human CD4+ T-cell activation via CD46 ligation.
@ast
Adenovirus type-35 vectors block human CD4+ T-cell activation via CD46 ligation.
@en
Adenovirus type-35 vectors block human CD4+ T-cell activation via CD46 ligation.
@nl
type
label
Adenovirus type-35 vectors block human CD4+ T-cell activation via CD46 ligation.
@ast
Adenovirus type-35 vectors block human CD4+ T-cell activation via CD46 ligation.
@en
Adenovirus type-35 vectors block human CD4+ T-cell activation via CD46 ligation.
@nl
prefLabel
Adenovirus type-35 vectors block human CD4+ T-cell activation via CD46 ligation.
@ast
Adenovirus type-35 vectors block human CD4+ T-cell activation via CD46 ligation.
@en
Adenovirus type-35 vectors block human CD4+ T-cell activation via CD46 ligation.
@nl
P2093
P2860
P356
P1476
Adenovirus type-35 vectors block human CD4+ T-cell activation via CD46 ligation.
@en
P2093
Constantinos Petrovas
Cornelia Gujer
Gunilla B Karlsson Hedestam
Jason G D Gall
Karin Loré
Richard A Koup
William C Adams
P2860
P304
P356
10.1073/PNAS.1017146108
P407
P577
2011-04-18T00:00:00Z